Thrombosis
HM20 Virtual
HM20 Virtual Product Theaters: Aug. 11-12
Hear from Dr. Javed Butler, chairman of the department of medicine at the University of Mississippi Medical Center, Jackson, to learn more about...
Clinical
Patent foramen ovale linked with increased risk of ischemic stroke in PE
Is patent foramen ovale (PFO) associated with increased risk of ischemic stroke in patients diagnosed with acute pulmonary embolism (PE)?
Clinical
No rise in major hemorrhagic events with antiplatelet therapy after ICH
Does the risk of increased recurrent intracerebral hemorrhage (ICH) exceed the benefits of decreased vaso-occlusive events for patients resuming...
Opinion
Hematologic manifestations of COVID-19
News
Low-dose prasugrel preserves efficacy but lowers bleeding in elderly
In an ISAR-REACT 5 substudy of elderly ACS patients, low-dose prasugrel was favored over ticagrelor.
News
New oral anticoagulants drive ACC consensus on bleeding
A new consensus document from the American College of Cardiology updates management of acute bleeding in patients on oral anticoagulants.
Clinical
Anticoagulation in cirrhosis: Best practices
How should the various coagulation abnormalities of cirrhosis be managed based on existing evidence?
Article
Endothelial injury may play a major role in COVID-19–associated coagulopathy
Clinical
Aspirin and warfarin together leads to increased bleeding without reducing thrombotic events
In patients taking warfarin for atrial fibrillation (AFib) or venous thromboembolism (VTE), how often is aspirin used without a clear indication,...
News
Ticagrelor gets FDA nod for DAPT in high-risk patients with CAD
The new indication is based on THEMIS, which comprised patients with CAD and type 2 diabetes without previous MI or stroke and showed clinical...